Alligator Bioscience Debt 2024

Alligator Bioscience Aktienanalyse

What does Alligator Bioscience do?

Alligator Bioscience AB is a biopharmaceutical company based in Lund, Sweden. The company was founded in 2001 and specializes in the development of innovative cancer therapies that harness the body's immune system to fight tumor cells. The company's business model is based on the research, development, and commercialization of biological drugs using highly specialized technologies such as antibody research and immuno-oncology. Alligator Bioscience works closely with leading research institutions and partners in the biotechnology and pharmaceutical industries. Its main focus is on developing antibodies against cancer using its patented technology platforms ALLIGATOR-GOLD® and ALLIGATOR-FAB®. These antibodies are highly effective, safe, and have a low side effect profile. Another important area of Alligator Bioscience's work is immuno-oncology, which involves activating and enhancing the body's own immune system to target and destroy cancer cells. The company has developed a range of innovative drugs in various stages of clinical development. One of its key products is ATOR-1017, a monoclonal antibody that targets the OX40 T-cell receptor and has shown promising results in activating the immune system against cancer in clinical trials. ADC-1013, an antibody targeting the PD-1 receptor, is another promising drug in development for the treatment of various types of cancer. Alligator Bioscience has a diverse portfolio of products and drugs focused on fighting cancer and works closely with research partners and customers to improve the effectiveness and safety of its products for market release. In summary, Alligator Bioscience is a leading company in cancer research and therapy, with an innovative technology platform and highly specialized drugs that have shown promising results. The company is continuously working to develop new and better cancer therapies. Alligator Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Alligator Bioscience's Debt Structure

Alligator Bioscience's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Alligator Bioscience's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Alligator Bioscience’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Alligator Bioscience’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Alligator Bioscience Stock

What is the debt of Alligator Bioscience this year?

Alligator Bioscience has a debt level of -50.02 SEK this year.

What was the debt of Alligator Bioscience compared to the previous year?

The debt of Alligator Bioscience has increased by -31.29% compared to the previous year dropped.

What are the consequences of high debt for investors in Alligator Bioscience?

High debt can pose a risk for investors of Alligator Bioscience, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Alligator Bioscience?

Low debt means that Alligator Bioscience has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Alligator Bioscience affect the company?

An increase in debt of Alligator Bioscience can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Alligator Bioscience affect the company?

A reduction in debt of Alligator Bioscience can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Alligator Bioscience?

Some factors that can influence the debt of Alligator Bioscience include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Alligator Bioscience so important for investors?

The debts of Alligator Bioscience are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Alligator Bioscience take to change the debt?

To change the debt, Alligator Bioscience can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Alligator Bioscience pay?

Over the past 12 months, Alligator Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Alligator Bioscience is expected to pay a dividend of 0 SEK.

What is the dividend yield of Alligator Bioscience?

The current dividend yield of Alligator Bioscience is .

When does Alligator Bioscience pay dividends?

Alligator Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Alligator Bioscience?

Alligator Bioscience paid dividends every year for the past 0 years.

What is the dividend of Alligator Bioscience?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Alligator Bioscience located?

Alligator Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alligator Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alligator Bioscience from 6/3/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did Alligator Bioscience pay the last dividend?

The last dividend was paid out on 6/3/2024.

What was the dividend of Alligator Bioscience in the year 2023?

In the year 2023, Alligator Bioscience distributed 0 SEK as dividends.

In which currency does Alligator Bioscience pay out the dividend?

The dividends of Alligator Bioscience are distributed in SEK.